Tamino Corp. accused medical equipment manufacturer
Boston Scientific’s RCE Pulsed RF Electrode products use methods for endoscopic targeting and infringe US Patent No. 9,446,229, which relates to a catheter using methods for applying high frequency energy to a region of the body for nerve stimulation, according to a complaint filed Wednesday in the US District Court for the Eastern District of Texas.
Boston Scientific confirmed in June 2019 its Cosman Medical Inc. unit received a letter from Tamino concerning the ‘299 patent and US Patent Nos. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.